Innovex International (INVX) Cash & Equivalents (2009 - 2026)

Innovex International (INVX) has 18 years of Cash & Equivalents data on file, last reported at $200.7 million in Q1 2026.

• Quarterly Cash & Equivalents rose 194.65% year-over-year to $200.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200.7 million (up 194.65% YoY) and the FY2025 annual result came in at $203.4 million, up 177.58% from the prior year.
• Cash & Equivalents fell to $200.7 million in Q1 2026, from $203.4 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $338.0 million in Q1 2022 to a low of $7.4 million in Q4 2023.
• A 5-year average of $137.7 million and a median of $99.9 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2023 — Cash & Equivalents plunged 97.14% — and 2024, when it surged 1102.54%.
• Tracing INVX's Cash & Equivalents over 5 years: stood at $8.4 million in 2022, then slipped by 12.0% to $7.4 million in 2023, then surged by 889.44% to $73.3 million in 2024, then soared by 177.58% to $203.4 million in 2025, then dropped by 1.33% to $200.7 million in 2026.
• The last three Cash & Equivalents figures came in at $200.7 million (Q1 2026), $203.4 million (Q4 2025), and $163.4 million (Q3 2025), per Business Quant data.